4 companies

Showing 1–4 of 4 companies

BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is a global rare disease biotechnology company developing genetic medicines, with nine approved therapies and operations in more than 70 countries.

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals is an RNAi therapeutics company developing gene-silencing medicines for TTR amyloidosis, acute hepatic porphyria and primary hyperoxaluria, from discovery through commercialisation.

Regeneron Pharmaceuticals, Inc (USA)

Regeneron Pharmaceuticals is a US-based biotechnology company that invents, develops, and commercializes medicines for serious diseases, with capabilities in antibody discovery and genetic medicine.

Moderna

Moderna is a biotechnology company that develops mRNA-based medicines, including vaccines for COVID-19 and RSV, with a pipeline spanning infectious diseases, oncology, rare diseases, and other therapeutic areas.

4 companies

BioMarin Pharmaceutical Inc.

Alnylam Pharmaceuticals

Regeneron Pharmaceuticals, Inc (USA)

Moderna

Browse by market